News - BioSpace
WEBSeptember 12, 2024. ·. 4 min read. ·. Angela Gabriel. Load More. BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The latest biotech and pharmaceutical news ...
BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEB2024 Q2 Job Market Report: More People Competing for Fewer Job Openings. For the second quarter of 2024, there were 25% fewer jobs posted live on BioSpace compared to the same quarter of 2023. The year-over-year job response rate rose from 14.6% to 15.3%. July 11, 2024. ·.
HEK 293 Cells: Background, Advantages and Applications
WEBJun 18, 2021 · Human Embryonic Kidney 293 (HEK 293) cells are one of the most frequently used cell lines for biotechnology and research studies. These cells are popular because they are fast-growing and robust. Additionally, due to the efficiency of HEK 293 cells, they generate exogenous proteins used in biomedical and pharmaceutical research.
AstraZeneca’s Imfinzi Scores Lung Cancer Wins With FDA’s
WEBAug 16, 2024 · AstraZeneca touted two lung cancer victories on Thursday with its blockbuster PD-1 inhibitor Imfinzi (durvalumab) securing the FDA’s nod for a perioperative label expansion in non-small cell lung cancer, as well as the regulator’s Priority Review and Breakthrough Therapy designations for small cell lung cancer.. The perioperative approval came as a bit of a surprise.
Novo’s Semaglutide Potentially Linked to Higher Risk of Suicidal ...
WEBAug 21, 2024 · Novo Nordisk ’s blockbuster GLP-1 treatment semaglutide—sold as Ozempic for type 2 diabetes and Wegovy for obesity—appears to be associated with a higher risk of suicidal ideation versus other drugs, according to a new study that drew from the World Health Organization’s safety database.. The results, published Tuesday in JAMA Network Open, are based on the WHO’s repository which ...
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for ...
WEBAug 14, 2024 · Imfinzi is an intravenous PD-L1 blocking antibody that works by preventing the ligand’s interaction with its receptor, disrupting the cancer cells’ ability to evade and suppress the immune system. The mechanism of action also boosts the anti-cancer activity of T-cells. Imfinzi is indicated for various cancers including non-small cell lung ...
The Top 6 Pharmaceutical Companies in New Jersey - BioSpace
WEBJun 23, 2017 · 6. Bristol Myers Squibb. New York City, N.Y. Jobs. 1. Johnson & Johnson. Johnson & Johnson has remained in the top spot on this list for many years. The company is headquartered in New Brunswick, NJ and employs over 140,000 people worldwide. J&J’s products include over-the-counter medications, medical devices and …
How to Write an Effective Cover Letter for a Research Scientist Job
WEBResearch scientists are a critical component of the life science industry. According to the Bureau of Labor Statistics (BLS), medical scientists earn a median annual salary of $84,810 and typically have a doctoral or professional degree.. Some may have an M.D. but conduct research in addition to, or instead of, practicing as a physician. The BLS projects job growth for medical scientists at a ...
Biopharma Mergers & Acquisitions - BioSpace
WEBLilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech. Eli Lilly is expanding its radiopharmaceutical portfolio with a $140 million upfront payment to Radionetics Oncology and the exclusive future right …
BioSpace
WEBBioSpace
Skip to content